Navigation Links
Team uses antisense technology that exploits gene splicing mechanism to kill cancer cells
Date:10/31/2012

Cold Spring Harbor, N.Y. Cancer cells grow fast. That's an essential characteristic of what makes them cancer cells. They've crashed through all the cell-cycle checkpoints and are continuously growing and dividing, far outstripping our normal cells. To do this they need to speed up their metabolism.

CSHL Professor Adrian Krainer and his team have found a way to target the cancer cell metabolic process and in the process specifically kill cancer cells.

Nearly 90 years ago the German chemist and Nobel laureate Otto Warburg proposed that cancer's prime cause was a change in cell metabolism i.e., in cells' production and consumption of energy. In particular cancer cells have a stubborn propensity to eschew using glucose as a source to generate energy. This is known as the Warburg Effect.

While metabolic changes are an important feature in the transformation of normal cells into cancer cells they are not now thought to be cancer's primary cause. Despite this, metabolic changes remain an attractive target for cancer therapy, as Krainer and colleagues show in a paper published online today in Open Biology, the open-access journal of Great Britain's Royal Society.

One difference between metabolism in cancer and normal cells is the switch in cancer to the production of a different version, or isoform, of a protein produced from the pyruvate kinase-M (PK-M) gene. The protein version produced in normal cells is known as PK-M1, while the one produced by cancer cells is known as PK-M2.

PK-M2 is highly expressed in a broad range of cancer cells. It enables the cancer cell to consume far more glucose than normal, while using little of it for energy. Instead, the rest is used to make more material with which to build more cancer cells.

PK-M1 and PK-M2 are produced in a mutually exclusive manner -- one-at-a-time, from the same gene, by a mechanism known as alternative splicing. When a gene's DNA is being copied i
'/>"/>

Contact: Edward Brydon Ph.D.
ebrydon@cshl.edu
917-476-6633
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Labor der Zukunft -- Tomorrows laboratory technology
2. The future of plant science - a technology perspective
3. The future of plant science a technology perspective
4. Ultracold matter technology from CU and SRI International licensed to Boulders ColdQuanta
5. UF researchers look for ways to make an emerging technology safe for environment
6. Breast cancer risk gene discovery fast tracked by new technology
7. Obese patients face higher radiation exposure from CT scans -- but new technology can help
8. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
9. Powerful sequencing technology decodes DNA folding pattern
10. New technology tracks sparrow migration for first time from California to Alaska
11. M2SYS Technology Partners with Hitachi to Offer Innovative Biometric Finger Vein Scanner to US Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015   Medisafe ™, ... million users across iOS and Android ... begun integrating biofeedback into the platform to allow patients ... outcomes. For the first time, patients will be able ... a dose impacts important biometrics, such as glucose levels ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and ... addition of the "Global Iris Recognition Market 2015-2019" ... forecast the Global Iris Recognition market to grow at ... This report covers the present scenario and ... for the period 2015-2019. To calculate the market size, ...
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs , ... company, today announced that the Company will demonstrate multiple ... enterprise and consumers at Connect:ID on March 23 through ... HOYOS Labs will highlight the IEEE Biometric Open Protocol ... ; and enterprise access control system. BOPS was invented ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... to someone speak, we construct rich mental models that allow ... mental states and contexts. This ability to understand written or ... human mind and central to everyday social life. In a ... underlie discourse comprehension. The study appears in Brain ...
... Mo. Fish, unlike humans, can regenerate nerve connections and ... Now, University of Missouri researchers have discovered how the sea ... long nerve "highways" that link the brain to the spinal ... humans who have suffered spinal cord injuries. "There is ...
... have developed a bio-based solar cell. They embedded the ... are responsible of photosynthesis, into complex molecules developed in-house, ... Dr Wolfgang Schuhmann from the Department of Analytical Chemistry ... Matthias Rgner from the Department of Plant Biochemistry, the ...
Cached Biology News:Researchers map brain areas vital to understanding language 2MU research sheds light on nerve regeneration following spinal cord injury 2Bio-based solar cell 2
(Date:4/30/2015)... April 30, 2015 Oxford Finance LLC ("Oxford"), ... life sciences and healthcare services companies, today announced the ... agreement with Celula, Inc., a diagnostic testing company focused ... better patient care and improved outcomes.  Proceeds of the ... expand the commercialization of its products in the U.S. ...
(Date:4/30/2015)... , April 30, 2015  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, today announced that it ... Thursday, May 7, 2015 after the close of the ... call and webcast on Thursday, May 7, 2015 at ... the results and recent corporate developments. For ...
(Date:4/30/2015)... 2015 SureClinical, a leader in cloud-based ... has joined SureClinical’s executive team as Chief Financial Officer. ... technology executive with over 25 years in leadership roles ... , Ms. Morris joins SureClinical from Marrone Bio Innovations ... CFO of MBI from its founding in 2006 until ...
(Date:4/29/2015)... April 29, 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") ... 31, 2014. Biorem,s complete fiscal 2014 year-end financial statements and MD&A have ... , 2013 , 2014 , 2013 ... 19,596 Gross profit 1,326 , 1,703 , ... 1,493 , 3,377 , 4,562 Ebitda* 92 ...
Breaking Biology Technology:Oxford Finance Provides $10 Million Debt Financing to Celula 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 3Julie I. Morris Joins SureClinical as Chief Financial Officer 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4
... October 22, 2007 In a major feat of ... laser with a wide-range of potential applications in chemistry, ... nanoantenna, the device is capable of resolving the chemical ... cell, with unprecedented detail. , Spearheaded by graduate students ...
... Dr. Cindy Dennison Haines has,been named Managing ... for health and medical professionals. "We,re delighted ... managing,Physician,s Briefing,s editing and writing team," said Editor-in-Chief,Barry ... and,HealthDay, a leading daily health news service for ...
... Orchid Cellmark Inc.,(Nasdaq: ORCH ), a leading ... that it has signed a definitive purchase,agreement to ... a purchase price of $5.6 million in cash ... restricted common stock. The purchase price is,subject to ...
Cached Biology Technology:Harvard University engineers demonstrate quantum cascade laser nanoantenna 2Cynthia Haines, M.D., Named Managing Editor of Physician's Briefing News Wire 2Orchid Cellmark to Purchase ReliaGene Technologies, Inc. 2Orchid Cellmark to Purchase ReliaGene Technologies, Inc. 3